scholarly article | Q13442814 |
P50 | author | Rebecca L. McCall | Q41781274 |
Rachael W Sirianni | Q41781277 | ||
Kyle T Householder | Q56994044 | ||
P2093 | author name string | Alesia V Prakapenka | |
Danielle M DiPerna | |||
Eugene P Chung | |||
P2860 | cites work | Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. | Q27311418 |
Camptothecins: a review of their chemotherapeutic potential | Q28203339 | ||
The blood-spinal cord barrier: morphology and clinical implications | Q28240807 | ||
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes | Q29617554 | ||
Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model | Q34198939 | ||
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology | Q34328650 | ||
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? | Q34367038 | ||
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. | Q34447986 | ||
Adsorption of plasma proteins on uncoated PLGA nanoparticles. | Q34581713 | ||
Transvascular delivery of small interfering RNA to the central nervous system. | Q34638044 | ||
Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease | Q34722724 | ||
Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography | Q34764435 | ||
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma | Q34789136 | ||
Pathogen-inspired drug delivery to the central nervous system | Q34929922 | ||
Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas | Q35841577 | ||
Rabies virus receptors | Q36086325 | ||
Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles | Q36247616 | ||
Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord | Q36633104 | ||
Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging | Q36638691 | ||
Strategy for effective brain drug delivery. | Q37760347 | ||
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status | Q38135674 | ||
The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems | Q38175442 | ||
Functional nanoparticles in targeting glioma diagnosis and therapies | Q38204417 | ||
Nanocarrier-based therapies for CNS tumors | Q38233169 | ||
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging | Q39136552 | ||
Targeted imaging of activated caspase-3 in the central nervous system by a dual functional nano-device | Q39278038 | ||
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. | Q39559308 | ||
RVG-mediated calpain2 gene silencing in the brain impairs learning and memory | Q39567298 | ||
RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain | Q39662401 | ||
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited | Q39911958 | ||
Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury | Q39942829 | ||
Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. | Q39961374 | ||
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. | Q41619756 | ||
PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. | Q41781215 | ||
Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor | Q44090700 | ||
Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide | Q45360534 | ||
Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles | Q45384244 | ||
Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles | Q48169419 | ||
Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier | Q48310007 | ||
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. | Q48614110 | ||
Measurement of cerebral blood volume in mouse brain regions using micro-computed tomography | Q48663323 | ||
Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury | Q50218527 | ||
Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells. | Q51161893 | ||
Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. | Q51475399 | ||
GABAA and GABAB receptor site distribution in the rat central nervous system | Q70180394 | ||
A rapid method for removal of the spinal cord | Q70193245 | ||
Targeted delivery of large fusion protein into hippocampal neurons by systemic administration | Q85173790 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | Pt A | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
drug delivery | Q1392806 | ||
P304 | page(s) | 89-97 | |
P577 | publication date | 2015-10-12 | |
P1433 | published in | Journal of Controlled Release | Q6295046 |
P1476 | title | A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system | |
P478 | volume | 220 |